Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy

Intracellular Trafficking of the KV1.3 Potassium Channel Is Regulated by the Prodomain of a Matrix Metalloprotease

(2013) Hai M. Nguyen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Matrix Metalloproteinases

(2012) Laurie A. Shuman Moss et al.   AMERICAN JOURNAL OF PATHOLOGY

Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma

(2012) Elisabeta Candrea et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis

(2012) A. R. Gocke et al.   JOURNAL OF IMMUNOLOGY

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

(2012) Joannes FM Jacobs et al.   LANCET ONCOLOGY

Matrix Metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12- and OX40L-Dependent Pathway

(2011) Emmanuelle Godefroy et al.   CANCER CELL

Bioelectric controls of cell proliferation: Ion channels, membrane voltage and the cell cycle

(2011) Douglas J. Blackiston et al.   CELL CYCLE

Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival

(2011) Jonathan R. Brody et al.   CELL CYCLE

Immunologic considerations for generating memory CD8 T cells through vaccination

(2011) Noah S. Butler et al.   CELLULAR MICROBIOLOGY

Immunotherapy for melanoma

(2011) Jeffrey Weber   CURRENT OPINION IN ONCOLOGY

Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma

(2011) Anne C. Knol et al.   EXPERIMENTAL DERMATOLOGY

Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes

(2011) Diego Sbardella et al.   MOLECULAR ASPECTS OF MEDICINE

The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis

(2010) Qian Qian et al.   CANCER INVESTIGATION

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Regulation of matrix metalloproteinase activity in health and disease

(2010) Elin Hadler-Olsen et al.   FEBS Journal

Immunotherapy for Melanoma: Current Status and Perspectives

(2010) Doru T. Alexandrescu et al.   JOURNAL OF IMMUNOTHERAPY

Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients

(2010) Min Li et al.   LUNG CANCER

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma

(2010) Andrea Ladányi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Updated Biological Roles for Matrix Metalloproteinases and New “Intracellular” Substrates Revealed by Degradomics

(2009) Georgina S. Butler et al.   BIOCHEMISTRY

The Immune System and Cancer

(2009) David Loose et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

(2009) Srikant Rangaraju et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Potassium Channel Modulation by a Toxin Domain in Matrix Metalloprotease 23

(2009) Srikant Rangaraju et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer

(2009) Roopali Roy et al.   JOURNAL OF CLINICAL ONCOLOGY

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

(2009) Karl S. Peggs et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IFN-  Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity

(2009) A. G. Sikora et al.   JOURNAL OF IMMUNOLOGY

Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database

(2008) P. M. McGowan et al.   ANNALS OF ONCOLOGY

Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block

(2008) Melanie P. Matheu et al.   IMMUNITY

Signaling defects in anti-tumor T cells

(2008) Alan B. Frey et al.   IMMUNOLOGICAL REVIEWS

Phase- and Stage-Related Proportions of T Cells Bearing the Transcription Factor FOXP3 Infiltrate Primary Melanoma

(2007) Giuseppe De Panfilis et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY